Blog
Bispecific LV20.19 CAR T Cells Induce 92% CR Rate in Relapsed/Refractory Mantle Cell Lymphoma
Mantle cell lymphoma (MCL) is an aggressive B-cell malignancy that
March 19, 2023
Mantle cell lymphoma (MCL) is an aggressive B-cell malignancy that
Many ovarian tumors contain mesothelin. Researchers wanted to test three
CAR T cells have shown some success in the clinic
T-cell transfer therapies have not yet been successfully applied to
Lymphomas can begin in the brain or spinal cord, or
T-cell transfer therapies have not yet been successfully applied to
Surgery can be curative when a solid tumor cancer has
The immune system can induce metabolic adaptations in tumor cells
Until recently, most CAR-T therapies were made from the patient’s